A0A6I9I9S6 (A0A6I9I9S6_VICPA) Vicugna pacos (Alpaca) (Lama pacos)
Dual specificity tyrosine-phosphorylation-regulated kinase 1A UniProtKBInterProInteractive Modelling
763 aa; Sequence (Fasta) ;
9 identical sequences: Equus caballus: A0A3Q2I3Y0; Equus asinus: A0A9L0K5Y6; Homo sapiens: Q13627; Pongo abelii: A0A2J8UAI1; Pan troglodytes: H2QL08, A0A6D2WLE2; Camelus ferus: A0A8B8RZL9; Microcebus murinus: A0A8C5VDN6; Pteropus vampyrus: A0A6P3QPJ4
It is possible new templates exist for this target since these models were created.
Available Structures
81 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Human Dual-Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A in complex with a consensus sub… |
Heteromer Q13627; Q5IJ48; | 1×D15; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A in complex with AZ191 | homo-4-mer | 4×QS0; 32×EDO; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of human DYRK1A in complex with compound 14 | monomer | 6×SO4; 1×9OF; 1×PGE; | ||||
| Assess | ||||||
| Human DYRK1A in complex with Leucettine L41 | monomer | 1×3RA; | ||||
| Assess | ||||||
| Crystal Structure of DYRK1A with small molecule inhibitor | monomer | 3×SO4; 7×EDO; 1×KQK; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A complexed with FC162 inhibitor | monomer | 2×SO4; 2×PG4; 1×DMS; 1×JHW; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A with harmine-derivatized AnnH-75 inhibitor | monomer | 1×PG4; 1×4H5; | ||||
| Assess | ||||||
| DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133. | monomer | 1×Q8J; | ||||
| Assess | ||||||
| Crystal structure of DYRK1AA in complex with 10-Bromo-substituted 11H-indolo[3,2-c]quinolone-6-carb… | monomer | 5×SO4; 9×EDO; 1×4E3; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A in complex with 10-Chloro-substituted 11H-indolo[3,2-c]quinolone-6-carb… | monomer | 6×SO4; 12×EDO; 1×4E2; 1×IOD; | ||||
| Assess | ||||||
| DYRK1A in complex with hydroxy benzothiazole fragment | monomer | 1×QIV; | ||||
| Assess | ||||||
| DYRK1a in Complex with a Bromo-Triazolo-Pyridine | monomer | 2×IWU; 1×PG4; 1×PEG; 2×PGE; 1×GOL; 1×EPE; 1×1PE; 5×SO4; 3×CL; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A in complex with RD0392 | monomer | 1×4VZ; 3×GOL; | ||||
| Assess | ||||||
| human DYRK1A/harmine complex | monomer | 1×HRM; | ||||
| Assess | ||||||
| human DYRK1A/inhibitor complex | monomer | 1×EHB; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A in complex with RD0448 | monomer | 1×4WD; | ||||
| Assess | ||||||
| Human DYRK1A in complex with LDN-211898 | monomer | 1×AWR; 2×PO4; | ||||
| Assess | ||||||
| Crystal Structure of DYRK1A with small molecule inhibitor | monomer | 6×SO4; 1×KQW; | ||||
| Assess | ||||||
| Crystal Structure of DYRK1A with small molecule inhibitor | monomer | 6×SO4; 1×KRQ; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of DYRK1A with small molecule inhibitor | monomer | 1×KRK; 6×EDO; 1×DMS; 4×SO4; | ||||
| Assess | ||||||
| Crystal structure of the human DYRK1A kinase domain bound to abemaciclib | monomer | 2×FLC; 1×6ZV; 8×EDO; 1×PEG; 1×LI; | ||||
| Assess | ||||||
| Crystal structure of human DYRK1A in complex with compound 32 | monomer | 1×9OL; | ||||
| Assess | ||||||
| DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENT | monomer | 1×AJG; | ||||
| Assess | ||||||
| DYRK1A in complex with XMD7-117 | monomer | 1×B5T; | ||||
| Assess | ||||||
| DYRK1A in complex with XMD14-124 | monomer | 1×B6Z; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A in complex with rutin | monomer | 1×RUT; | ||||
| Assess | ||||||
| DYRK1A in complex with JWC-055 | monomer | 1×B6N; | ||||
| Assess | ||||||
| DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT | monomer | 1×Y3L; | ||||
| Assess | ||||||
| Crystal structure of human DYRK1A in complex with ARN25068 | monomer | 1×39I; | ||||
| Assess | ||||||
| Crystal Structure of DYRK1A with small molecule inhibitor | monomer | 1×SO4; 1×PG4; 1×KR8; | ||||
| Assess | ||||||
| DYRK1A in complex with XMD15-27-2 | monomer | 1×B6H; | ||||
| Assess | ||||||
| Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A | monomer | 1×D15; 1×CL; 3×P6G; 1×SO4; | ||||
| Assess | ||||||
| DYRK1A in complex with HG-8-60-1 | monomer | 1×B5Z; | ||||
| Assess | ||||||
| Crystal Structure of DYRK1A with small molecule inhibitor | monomer | 1×CL; 1×KQE; | ||||
| Assess | ||||||
| DYRK1A in complex with XMD8-49 | monomer | 1×B6B; | ||||
| Assess | ||||||
| DYRK1A in complex with XMD8-62e | monomer | 1×B7B; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A in complex with 10-Iodo-substituted 11H-indolo[3,2-c]quinoline-6-carbox… | monomer | 2×PG4; 2×SO4; 1×4E1; | ||||
| Assess | ||||||
| Human DYRK1A in complex with PKC412 | monomer | 1×2K2; | ||||
| Assess | ||||||
| DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT | monomer | 1×5PW; | ||||
| Assess | ||||||
| DYRK1A in complex with methoxy benzothiazole fragment | monomer | 1×7QQ; | ||||
| Assess | ||||||
| DYRK1A in complex with JWD-065 | monomer | 1×B6Q; | ||||
| Assess | ||||||
| DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT | monomer | 1×ZC3; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A complexed with KuFal319 (compound 11) | monomer | 3×PG4; 3×SO4; 1×MLW; | ||||
| Assess | ||||||
| DYRK1A in complex with XMD7-112 | monomer | 1×B7W; | ||||
| Assess | ||||||
| DYRK1A bound to a harmine derivative | monomer | 1×QKG; 3×PG4; | ||||
| Assess | ||||||
| DYRK1A with PST001 | monomer | 1×OPW; | ||||
| Assess | ||||||
| Crystal Structure of DYRK1A with small molecule inhibitor | monomer | 3×SO4; 1×KQZ; 3×EDO; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with AMPNP | monomer | 1×ANP; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A in complex with gossypin | monomer | 1×R7O; 1×ACT; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 8 | monomer | 1×QZ2; | ||||
| Assess | ||||||
| The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor | monomer | 1×2C3; 2×1PE; 2×SO4; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with complex 10 | monomer | 1×MFR; | ||||
| Assess | ||||||
| A natural inhibitor of DYRK1A for treatment of diabetes mellitus | monomer | 1×EKU; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 3 | monomer | 1×QYH; | ||||
| Assess | ||||||
| Crystal structure of DYRK1A in complex with CX-4945 | monomer | 1×3NG; 5×SO4; 2×PG4; 1×PEG; 3×EDO; | ||||
| Assess | ||||||
| The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor | monomer | 1×2C4; 2×1PE; 2×SO4; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 16 | monomer | 2×CL; 1×QYW; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 4 | monomer | 1×6SD; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 54 | monomer | 1×RK2; 1×DMS; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 5 | monomer | 1×QYK; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 50 | monomer | 1×RK5; 1×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 25 | monomer | 1×RJ8; 2×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 3 | monomer | 1×RJ5; 2×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 53 | monomer | 1×RHH; 1×PO4; 1×DMS; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 38 | monomer | 1×RKK; 1×CL; | ||||
| Assess | ||||||
| tructure of DYRK1A in complex with compound 24 | monomer | 1×QZW; 1×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 28 | monomer | 1×RJ2; 2×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 7 | monomer | 1×QYZ; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 51 | monomer | 1×RKZ; 1×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 58 | monomer | 1×RK8; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 34 | monomer | 1×R05; 1×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 56 | monomer | 1×RJZ; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 5 | monomer | 1×RHZ; 2×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 10 | monomer | 1×RHW; 2×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 46 | monomer | 1×RKQ; 2×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 16 | monomer | 1×RHT; 2×CL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 2 | monomer | 1×QYE; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 1 | monomer | 1×QY8; 1×DMS; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 6 | monomer | 1×QYB; 2×PO4; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 33 | monomer | 1×RKH; 1×GOL; | ||||
| Assess | ||||||
| Structure of DYRK1A in complex with compound 32 | monomer | 1×RKW; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3anr.1.A | monomer | 0.83 | 1×HRM; | 100.00 | ||
| Assess | ||||||